Church & Dwight Scans For Acquisition Targets Following Avid Gummies
This article was originally published in The Rose Sheet
With the integration of gummy vitamin maker Avid Health complete, Church & Dwight is free to explore further acquisition opportunities, CEO Craigie says. In the meantime, the company is considering expanding gummies into the OTC drug category – a potential “grand slam” if the firm can address regulatory, manufacturing and marketing concerns.
You may also be interested in...
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.